Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndromeGain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillationMultiple arrhythmic syndromes in a newborn, owing to a novel mutation in SCN5AElectrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleevesAZD1305 exerts atrial predominant electrophysiological actions and is effective in suppressing atrial fibrillation and preventing its reinduction in the dogFunctional effects of KCNE3 mutation and its role in the development of Brugada syndromeLoss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac deathGenetic basis of Brugada syndromeThe Early Repolarization Pattern: A Consensus PaperThe role of late I Na in development of cardiac arrhythmiasJ-wave syndromes: Brugada and early repolarization syndromesInduced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery.Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6)Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndromeGenetic basis and molecular mechanism for idiopathic ventricular fibrillationValue of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutationsCommon variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac deathContemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and FSodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal heartsThe homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradientAmerican Heart Association atrial fibrillation research summit: a conference report from the American Heart AssociationEffect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome.Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data.Proposed diagnostic criteria for the Brugada syndrome: consensus report.Brugada syndrome: 1992-2002: a historical perspective.Brugada syndrome.Short QT syndrome. Genotype-phenotype correlationsTpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome.Is a narrow and tall QRS complex an ECG marker for sudden death?Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndromeMode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndromeOverlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2A complete right bundle-branch block masking Brugada syndromeRisk stratification in Brugada syndrome: Clinical characteristics, electrocardiographic parameters, and auxiliary testing.Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene.A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotypeGenetics and Sinus Node Dysfunction.Differential effects of the transient outward K(+) current activator NS5806 in the canine left ventricleAbnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome.KCNE2 modulation of Kv4.3 current and its potential role in fatal rhythm disorders.
P50
Q24300388-93BE990E-F667-44E0-9484-589E27029A7CQ24320049-3788A8CF-BEC0-4979-AD19-A48191753032Q24320049-C08D9AAD-D123-4975-9BD2-45976E1F6533Q24337302-430EE47A-EE14-4848-AA59-FE6EDBCF8A1CQ24601144-85B9719B-BFF3-4C56-8F1C-168AF1C8BB8FQ24607775-36DBF77F-E655-4EDA-8455-0B692671E1B5Q24607775-ED026089-B812-4D2F-B223-C93832B8C0C5Q24655604-4AC1F380-18B7-410A-9050-0A34DD951835Q24655604-5A74D187-31A0-4BF1-9E12-119BDEBF2476Q24675134-1803D4EC-B729-4045-8B6F-E36C316EF369Q24681917-1FCCAD07-1F72-4852-A871-8B3FFB97B564Q24681917-50CF10DD-F7E4-4738-851B-52DC62415E62Q26800041-934A6952-4471-4C28-AB7A-B50A394EA2B3Q26823149-68B2D157-EFC4-45C7-BD5C-2B680DF4418DQ26859366-06218369-6770-42B3-A3FE-85448BF57033Q27693217-39871591-1767-4576-BEAE-6B1648E87759Q27693217-EBDFF59E-2F17-433C-A371-30634709B9E5Q28117761-F654206E-769D-4EBC-9D35-2B6CF663E578Q28118648-C023714E-3F0E-4464-8320-0A874A3A30CEQ28118648-FF593D13-594A-4D5E-BB43-8894912831C3Q28265902-CF8E8E0E-CCEE-4389-B4F2-D52B5A902661Q28291121-500A3C1F-1592-49A1-B0F4-9E26E2E377A3Q28294931-CC1C59BA-1E6E-4646-9A60-0D92811DC6D9Q28304085-DBE1C3D6-722E-4E45-AA2C-3B533BA2CA38Q28369798-BA59FCB3-0B55-4737-A91F-153F306A9844Q28587676-00744966-677C-419D-A69D-B08039C8813CQ28587676-99E818E0-52BA-4F46-B0CA-393289C1A6D1Q30425918-B0EF4B5E-42AA-4AEF-AC9F-2BF5520B7CC6Q30541203-04463CE1-F4D3-4F3C-8644-5A9D72CBD0BEQ31136281-0AF44CCD-78EA-42C8-8417-9EA0A7BD1F01Q33148286-3C2A5876-539B-474E-8920-74A808484E73Q33148990-B5BE3AE9-69FF-4BE3-B7F0-9AC38F3AF092Q33152662-A16CC2D8-668B-47E6-9E40-CFA6982D3677Q33152662-DEEB98FF-41BC-4F67-9B61-56D082A381BAQ33153179-60B304A5-56A7-4B99-A84C-A19B48EF73B1Q33153179-C68696A2-D33A-47E4-8228-DD5235F39DD8Q33153802-076EEF6A-46D3-4BB2-9768-7398B83CB04BQ33153802-A6070087-2431-450E-B5E8-84989D3F76F6Q33156610-9D0A62E1-6768-4B69-A496-7B4DC0D39B19Q33156610-D68393DF-23A8-4762-8CDB-FF28628A88A5
P50
description
Amerikaans onderzoeker
@nl
hulumtues
@sq
investigador estadounidense
@es
investigador estauxunidense
@ast
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Charles Antzelevitch
@af
Charles Antzelevitch
@an
Charles Antzelevitch
@ast
Charles Antzelevitch
@bar
Charles Antzelevitch
@br
Charles Antzelevitch
@ca
Charles Antzelevitch
@co
Charles Antzelevitch
@cs
Charles Antzelevitch
@cy
Charles Antzelevitch
@da
type
label
Charles Antzelevitch
@af
Charles Antzelevitch
@an
Charles Antzelevitch
@ast
Charles Antzelevitch
@bar
Charles Antzelevitch
@br
Charles Antzelevitch
@ca
Charles Antzelevitch
@co
Charles Antzelevitch
@cs
Charles Antzelevitch
@cy
Charles Antzelevitch
@da
prefLabel
Charles Antzelevitch
@af
Charles Antzelevitch
@an
Charles Antzelevitch
@ast
Charles Antzelevitch
@bar
Charles Antzelevitch
@br
Charles Antzelevitch
@ca
Charles Antzelevitch
@co
Charles Antzelevitch
@cs
Charles Antzelevitch
@cy
Charles Antzelevitch
@da
P1015
P214
P244
P268
P1015
P1153
7101704673
P1207
n2009144619
P21
P213
0000 0001 1618 3348
P214
P244
P268
P31
P496
0000-0001-7349-1582
P569
2000-01-01T00:00:00Z
P735
P7859
lccn-n82234594